{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:34:41Z","timestamp":1793370881066,"version":"4.5.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Gene delivery and the various routes of administration used to deliver viral vectors constitute a rapidly evolving field, with recent success in restoring hearing in children with\n                      <jats:italic toggle=\"yes\">OTOF<\/jats:italic>\n                      variants in ongoing clinical otoferlin trials. With the rise of gene therapy for major hereditary hearing disorders, both syndromic and nonsyndromic, there has been parallel progress in the development of new delivery methods. Advances in intratympanic injection of antibiotics and corticosteroids, along with nearly half a century of experience in cochlear implantation surgery, have enabled multiple local and systemic approaches to access the inner ear. Recent industry investment in gene therapy and delivery technologies has accelerated scientific progress, underscoring the need for continuous evaluation of the most suitable gene delivery strategies for different causes of hearing loss. Although most gene delivery in animal models has been performed via round window membrane injection, yielding promising results in cochlear hair cell transduction, potential drawbacks remain for clinical translation\u2014particularly limited vector distribution, which may result in a basal-to-apical gradient. Venting procedures such as stapes footplate fenestration or canalostomy have been explored to mitigate these limitations, and recent intrathecal or even in utero injections have been investigated as alternative approaches. Hearing loss can be inherited in multiple ways, and patient treatment with gene delivery, or even the type of gene therapy itself, may vary with the recent success of CRISPR\/Cas-based editing tools. Understanding the genetic etiology of inner ear disorders has facilitated the identification of therapeutic targets and innovative delivery approaches. This review summarizes the current understanding of delivery routes for gene therapy, highlighting their respective strengths and limitations as demonstrated in translational and clinical research to date. Furthermore, it examines advances in drug delivery and clinical applications in the context of emerging therapeutics, providing an integrated overview and perspective on the future direction of gene delivery strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aud.0000000000001771","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:00:37Z","timestamp":1791914437000},"page":"1522-1530","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gene Therapy: Routes of Inner Ear Delivery"],"prefix":"10.1097","volume":"47","author":[{"given":"Erdem","family":"Yildiz","sequence":"first","affiliation":[{"name":"Christian Doppler Laboratory for Inner Ear Research, Division of Head and Neck Surgery, Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Arnoldner","sequence":"additional","affiliation":[{"name":"Christian Doppler Laboratory for Inner Ear Research, Division of Head and Neck Surgery, Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1073\/pnas.1817537116","article-title":"Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model.","volume":"116","author":"Akil","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41467-022-28969-3","article-title":"Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate.","volume":"13","author":"Andres-Mateos","year":"2022","journal-title":"Nat Commun"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40136-022-00426-1","article-title":"The augmented cochlear implant: A convergence of drugs and cochlear implantation for the treatment of hearing loss.","volume":"10","author":"Arambula","year":"2022","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/BF02439718","article-title":"The cochlear aqueduct in pediatric temporal bones.","volume":"254","author":"Bachor","year":"1997","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omtm.2021.03.005","article-title":"Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss.","volume":"21","author":"Bankoti","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/MAO.0000000000001162","article-title":"Cochlear implants in adults: Effects of age and duration of deafness on speech recognition.","volume":"37","author":"Beyea","year":"2016","journal-title":"Otol Neurotol"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph.","volume":"28","author":"Bird","year":"2007","journal-title":"Otol Neurotol"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"783504","DOI":"10.3389\/fcell.2021.783504","article-title":"A single cisterna magna injection of AAV leads to binaural transduction in mice.","volume":"9","author":"Blanc","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss.","volume":"378","author":"Brock","year":"2018","journal-title":"N Engl J Med"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.09.003","article-title":"Inner ear drug delivery via a reciprocating perfusion system in the guinea pig.","volume":"110","author":"Chen","year":"2005","journal-title":"J Control Release"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/lary.25317","article-title":"Cochlear gene transfer mediated by adeno-associated virus: Comparison of two surgical approaches.","volume":"125","author":"Chien","year":"2015","journal-title":"Laryngoscope"},{"key":"R13-20261030","first-page":"e2409353","article-title":"Nature inspired delivery vehicles for CRISPR-based genome editing.","author":"Clarissa","year":"2025","journal-title":"Small"},{"key":"R14-20261030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in vivo gene therapy.","volume":"8","author":"Colella","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"1207141","DOI":"10.3389\/fphar.2023.1207141","article-title":"Overcoming barriers: A review on innovations in drug delivery to the middle and inner ear.","volume":"14","author":"Delaney","year":"2023","journal-title":"Front Pharmacol"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2217\/fvl.13.112","article-title":"Adeno-associated virus structural biology as a tool in vector development.","volume":"8","author":"Drouin","year":"2013","journal-title":"Future Virol"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.ymthe.2023.05.005","article-title":"Rescue of auditory function by a single administration of AAV-TMPRSS3 gene therapy in aged mice of human recessive deafness DFNB8.","volume":"31","author":"Du","year":"2023","journal-title":"Mol Ther"},{"key":"R18-20261030","first-page":"29","article-title":"Dual vector expansion of the recombinant AAV packaging capacity.","volume":"219","author":"Duan","year":"2003","journal-title":"Methods Mol Biol"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/2625","article-title":"Peroral gene therapy of lactose intolerance using an adeno-associated virus vector.","volume":"4","author":"During","year":"1998","journal-title":"Nat Med"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10162-025-01009-9","article-title":"Magnetic targeting of AAV gene therapy for inner ear following systemic delivery: Preliminary findings and transduction pattern in rat cochlea.","volume":"26","author":"Ferdous","year":"2025","journal-title":"J Assoc Res Otolaryngol"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.1947.02880020013004","article-title":"Otic complications of streptomycin therapy: A preliminary report.","volume":"133","author":"Fowler","year":"1947","journal-title":"J Am Med Assoc"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.heares.2018.06.017","article-title":"Anatomical basis of drug delivery to the inner ear.","volume":"368","author":"Glueckert","year":"2018","journal-title":"Hear Res"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2018.11.003","article-title":"Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of Usher syndrome 3a and transduces hair cells in a non-human primate.","volume":"13","author":"Gy\u00f6rgy","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10544-025-00751-4","article-title":"Novel dual-lumen microneedle delivers adeno-associated viral vectors in the guinea pig inner ear via the round window membrane.","volume":"27","author":"Hammer","year":"2025","journal-title":"Biomed Microdevices"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"F81","DOI":"10.1136\/fn.71.2.F81","article-title":"Development of fetal hearing.","volume":"71","author":"Hepper","year":"1994","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/AUD.0b013e3182741aa7","article-title":"Factors affecting open-set word recognition in adults with cochlear implants.","volume":"34","author":"Holden","year":"2013","journal-title":"Ear Hear"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"114153","DOI":"10.1016\/j.jconrel.2025.114153","article-title":"Round window membrane extracellular vesicles facilitate inner ear drug delivery.","volume":"387","author":"Holdsclaw","year":"2025","journal-title":"J Control Release"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000501331","article-title":"Sustained-release triamcinolone acetonide hydrogels reduce hearing threshold shifts in a model for cochlear implantation with hearing preservation.","volume":"24","author":"Honeder","year":"2019","journal-title":"Audiol Neurootol"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.omtm.2020.06.019","article-title":"Efficient in utero gene transfer to the mammalian inner ears by the synthetic adeno-associated viral vector anc80L65.","volume":"18","author":"Hu","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/1756-185X.14518","article-title":"Intrathecal injection of methotrexate combined with dexamethasone for Cogan\u2019s syndrome with neurological involvement: A case report and literature review.","volume":"26","author":"Hu","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"R31-20261030","article-title":"Cell-specific delivery of GJB2 restores auditory function in mouse models of DFNB1 deafness and mediates appropriate expression in NHP cochlea.","author":"Ivanchenko","year":"2024","journal-title":"bioRxiv"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"107930","DOI":"10.1016\/j.heares.2020.107930","article-title":"Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea.","volume":"394","author":"Ivanchenko","year":"2020","journal-title":"Hear Res"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.omtm.2021.03.019","article-title":"AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear.","volume":"21","author":"Ivanchenko","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R34-20261030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/gt.2015.22","article-title":"Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.","volume":"22","author":"Jie","year":"2015","journal-title":"Gene Ther"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gt.2010.175","article-title":"Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear.","volume":"18","author":"Kilpatrick","year":"2011","journal-title":"Gene Ther"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1080\/10717544.2021.1992041","article-title":"Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.","volume":"28","author":"Kim","year":"2021","journal-title":"Drug Deliv"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1172\/jci.insight.173052","article-title":"Semicircular canal drug delivery safely targets the inner ear perilymphatic space.","volume":"9","author":"Kim","year":"2024","journal-title":"JCI Insight"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1288\/00005537-196007000-00004","article-title":"Method for the identification and localization of cerebrospinal fluid, rhinorrhea and otorrhea.","volume":"70","author":"Kirchner","year":"1960","journal-title":"Laryngoscope"},{"key":"R41-20261030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jconrel.2025.02.060","article-title":"Injectable polyplex-loaded glycol chitosan thermogel for efficient and safe inner ear gene delivery.","volume":"380","author":"Le","year":"2025","journal-title":"J Control Release"},{"key":"R42-20261030","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.2020.17647","article-title":"Hearing loss in children: A review.","volume":"324","author":"Lieu","year":"2020","journal-title":"JAMA"},{"key":"R44-20261030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5483\/BMBRep.2020.53.11.185","article-title":"Helper virus-free gutless adenovirus (HF-GLAd): A new platform for gene therapy.","volume":"53","author":"Liu","year":"2020","journal-title":"BMB Rep"},{"key":"R45-20261030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5144\/1658-3876.2011.51","article-title":"Viral-associated thrombotic microangiopathies.","volume":"4","author":"Lopes da Silva","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R46-20261030","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.otc.2004.04.001","article-title":"The history of intratympanic drug therapy in otology.","volume":"37","author":"Lustig","year":"2004","journal-title":"Otolaryngol Clin North Am"},{"key":"R47-20261030","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","article-title":"AAV1-hOTOF gene therapy for autosomal recessive deafness 9: A single-arm trial.","volume":"403","author":"Lv","year":"2024","journal-title":"Lancet"},{"key":"R48-20261030","doi-asserted-by":"crossref","first-page":"eabq3916","DOI":"10.1126\/scitranslmed.abq3916","article-title":"Delivery of gene therapy through a cerebrospinal fluid conduit to rescue hearing in adult mice.","volume":"15","author":"Mathiesen","year":"2023","journal-title":"Sci Transl Med"},{"key":"R49-20261030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/00016486509124579","article-title":"Development of hearing in the normal CBA-J mouse: Correlation of physiological observations with behavioral responses and with cochlear anatomy.","volume":"59","author":"Mikaelian","year":"1965","journal-title":"Acta Otolaryngol"},{"key":"R50-20261030","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease.","volume":"392","author":"Musunuru","year":"2025","journal-title":"N Engl J Med"},{"key":"R51-20261030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10162-006-0034-y","article-title":"Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex.","volume":"7","author":"Mynatt","year":"2006","journal-title":"J Assoc Res Otolaryngol"},{"key":"R52-20261030","doi-asserted-by":"crossref","first-page":"2242003","DOI":"10.1080\/10717544.2023.2242003","article-title":"Sustained delivery of triamcinolone acetonide from a thermosensitive microemulsion gel system for the treatment of sensorineural hearing loss.","volume":"30","author":"Nguyen","year":"2023","journal-title":"Drug Deliv"},{"key":"R53-20261030","doi-asserted-by":"crossref","first-page":"eaao0935","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci Transl Med"},{"key":"R54-20261030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fncel.2019.00261","article-title":"Inner ear therapeutics: An overview of middle ear delivery.","volume":"13","author":"Patel","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"R56-20261030","first-page":"EVIDoa2300172","article-title":"High-dose glucocorticoids for the treatment of sudden hearing loss.","volume":"3","author":"Plontke","year":"2024","journal-title":"NEJM Evid"},{"key":"R57-20261030","doi-asserted-by":"crossref","first-page":"892777","DOI":"10.3389\/fnins.2022.892777","article-title":"Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear.","volume":"16","author":"Plontke","year":"2022","journal-title":"Front Neurosci"},{"key":"R58-20261030","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/MLG.0b013e318058a06b","article-title":"Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane.","volume":"117","author":"Plontke","year":"2007","journal-title":"Laryngoscope"},{"key":"R60-20261030","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s13346-018-0539-z","article-title":"Intracochlear administration of steroids with a catheter during human cochlear implantation: A safety and feasibility study.","volume":"8","author":"Prenzler","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"R61-20261030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4939-3615-1_21","article-title":"An overview of nanoparticle based delivery for treatment of inner ear disorders.","volume":"1427","author":"Pyykko","year":"2016","journal-title":"Methods Mol Biol"},{"key":"R62-20261030","doi-asserted-by":"crossref","first-page":"e2306788","DOI":"10.1002\/advs.202306788","article-title":"AAV-mediated gene therapy restores hearing in patients with DFNB9 deafness.","volume":"11","author":"Qi","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"R63-20261030","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1038\/s41591-025-03773-w","article-title":"AAV gene therapy for autosomal recessive deafness 9: A single-arm trial.","volume":"31","author":"Qi","year":"2025","journal-title":"Nat Med"},{"key":"R64-20261030","doi-asserted-by":"crossref","first-page":"e2306201","DOI":"10.1002\/advs.202306201","article-title":"Preclinical efficacy and safety evaluation of AAV-OTOF in DFNB9 mouse model and nonhuman primate.","volume":"11","author":"Qi","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"R65-20261030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ymthe.2022.12.018","article-title":"Cochlear transduction via cerebrospinal fluid delivery of AAV in non-human primates.","volume":"31","author":"Ranum","year":"2023","journal-title":"Mol Ther"},{"key":"R67-20261030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/MAO.0b013e318263d56d","article-title":"Round window versus cochleostomy technique in cochlear implantation: Histologic findings.","volume":"33","author":"Richard","year":"2012","journal-title":"Otol Neurotol"},{"key":"R68-20261030","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: Expanding the scope of gene therapy.","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R69-20261030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1288\/00005537-195607000-00005","article-title":"Ablation therapy for the relief of Meniere\u2019s disease.","volume":"66","author":"Schuknecht","year":"1956","journal-title":"Laryngoscope"},{"key":"R70-20261030","first-page":"1","article-title":"Ablation therapy in the management of Meni\u00e8re\u2019s disease.","volume":"132","author":"Schuknecht","year":"1957","journal-title":"Acta Otolaryngol Suppl"},{"key":"R71-20261030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14712598.2013.779249","article-title":"New developments in lentiviral vector design, production and purification.","volume":"13","author":"Segura","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"R73-20261030","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1038\/s41598-017-09805-x","article-title":"Intravenous rAAV2\/9 injection for murine cochlear gene delivery.","volume":"7","author":"Shibata","year":"2017","journal-title":"Sci Rep"},{"key":"R74-20261030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/hum.2016.053","article-title":"Identification of adeno-associated viral vectors that target neonatal and adult mammalian inner ear cell subtypes.","volume":"27","author":"Shu","year":"2016","journal-title":"Hum Gene Ther"},{"key":"R75-20261030","doi-asserted-by":"crossref","first-page":"892969","DOI":"10.3389\/fbioe.2022.892969","article-title":"Improving control of gene therapy-based neurotrophin delivery for inner ear applications.","volume":"10","author":"St Peter","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"R76-20261030","doi-asserted-by":"crossref","first-page":"1054069","DOI":"10.3389\/fmmed.2022.1054069","article-title":"Strategies to improve safety profile of AAV vectors.","volume":"2","author":"Suoranta","year":"2022","journal-title":"Front Mol Med"},{"key":"R77-20261030","doi-asserted-by":"crossref","first-page":"45524","DOI":"10.1038\/srep45524","article-title":"Cochlear gene therapy with ancestral AAV in adult mice: Complete transduction of inner hair cells without cochlear dysfunction.","volume":"7","author":"Suzuki","year":"2017","journal-title":"Sci Rep"},{"key":"R78-20261030","doi-asserted-by":"crossref","first-page":"108141","DOI":"10.1016\/j.heares.2020.108141","article-title":"Novel 3D-printed hollow microneedles facilitate safe, reliable, and informative sampling of perilymph from guinea pigs.","volume":"400","author":"Szeto","year":"2021","journal-title":"Hear Res"},{"key":"R79-20261030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lio2.336","article-title":"Inner ear delivery: Challenges and opportunities.","volume":"5","author":"Szeto","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"R80-20261030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fncel.2019.00471","article-title":"Dye tracking following posterior semicircular canal or round window membrane injections suggests a role for the cochlea aqueduct in modulating distribution.","volume":"13","author":"Talaei","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"R81-20261030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00439-022-02504-2","article-title":"Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin.","volume":"142","author":"Tang","year":"2023","journal-title":"Hum Genet"},{"key":"R82-20261030","first-page":"4","article-title":"DB-OTO gene therapy for inherited deafness.","volume":"9","author":"Valayannopoulos","year":"2025","journal-title":"N Engl J Med"},{"key":"R83-20261030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery.","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R84-20261030","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41591-024-03023-5","article-title":"Bilateral gene therapy in children with autosomal recessive deafness 9: Single-arm trial results.","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"R85-20261030","first-page":"1155","article-title":"Ototoxicity of gentamicin. Histopathologic and functional results in the cat.","volume":"74","author":"Webster","year":"1970","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R86-20261030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/000348947808700105","article-title":"Studies on cochlear aqueduct patency.","volume":"87","author":"W\u0142odyka","year":"1978","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R87-20261030","doi-asserted-by":"crossref","first-page":"1062379","DOI":"10.3389\/fphar.2023.1062379","article-title":"Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics.","volume":"14","author":"Yildiz","year":"2023","journal-title":"Front Pharmacol"},{"key":"R88-20261030","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1038\/s41598-018-21233-z","article-title":"Enhanced viral-mediated cochlear gene delivery in adult mice by combining canal fenestration with round window membrane inoculation.","volume":"8","author":"Yoshimura","year":"2018","journal-title":"Sci Rep"},{"key":"R89-20261030","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1097\/MAO.0000000000002491","article-title":"Anatomical and functional consequences of microneedle perforation of round window membrane.","volume":"41","author":"Yu","year":"2020","journal-title":"Otol Neurotol"},{"key":"R90-20261030","doi-asserted-by":"crossref","first-page":"101154","DOI":"10.1016\/j.omtm.2023.101154","article-title":"Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates.","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R91-20261030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MAO.0000000000004366","article-title":"A novel delivery approach of clinical inner ear gene therapy.","volume":"46","author":"Zhang","year":"2025","journal-title":"Otol Neurotol"},{"key":"R92-20261030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/biom13010038","article-title":"Approaches and vectors for efficient cochlear gene transfer in adult mouse models.","volume":"13","author":"Zhao","year":"2022","journal-title":"Biomolecules"},{"key":"R93-20261030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.288.5467.877","article-title":"Seeing the herpesvirus capsid at 8.5 A.","volume":"288","author":"Zhou","year":"2000","journal-title":"Science"}],"container-title":["Ear &amp; Hearing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AUD.0000000000001771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:04:53Z","timestamp":1793369093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AUD.0000000000001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aud.0000000000001771","relation":{},"ISSN":["1538-4667","0196-0202"],"issn-type":[{"value":"1538-4667","type":"electronic"},{"value":"0196-0202","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"2025-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}